D-Wave and Japan Tobacco Collaborate on Quantum AI-Driven Drug Discovery Project
Portfolio Pulse from Benzinga Newsdesk
D-Wave Quantum Inc. and Japan Tobacco's pharmaceutical division are collaborating on a proof-of-concept project to use quantum computing and AI for drug discovery. The project aims to enhance the speed and quality of AI-driven drug design, potentially setting a new standard in the field.
October 01, 2024 | 11:15 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
D-Wave Quantum Inc. is collaborating with Japan Tobacco to use quantum computing and AI in drug discovery, potentially enhancing the speed and quality of drug design.
The collaboration with Japan Tobacco positions D-Wave Quantum as a key player in the innovative use of quantum computing in pharmaceuticals, likely boosting investor confidence and interest in QBTS.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90